Vaccine Weekly articles from September 2003

Vaccine Weekly archives from September 2003

Antibody fragments fused to IL-12 and to TNF-alpha exert anti-tumor effect.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- The combination of a tumor-targeting antibody fragment fused to interleukin 12 and to tumor necrosis factor alpha exerts a synergistic effect against tumors. "The potent antitumor activity of...

Biostatisticians demonstrate method to bolster accuracy of vaccine studies.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Is my illness serious enough to warrant a doctor visit? Do I have the flu or the common cold? These mundane questions posed by millions every year during flu season bedevil scientists who study...

Hepatitis vaccines: Recent advances.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- According to recent research published in the International Journal for Parasitology, "Despite the availability of hepatitis A vaccines that might provide protection for decades, hepatitis B vaccines...

23-Valent polysaccharide pneumococcal vaccine not effective in Navajo adults.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- The 23-valent polysaccharide vaccine against invasive pneumococcal disease was not effective in Navajo adults. According to a study from the United States, "Invasive pneumococcal disease occurs...

Many aspects of smallpox vaccination reviewed.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A review of smallpox vaccination, including background information, vaccination technique, normal vaccination and revaccination, and expected normal reactions, has been published in a recent issue of...

Proteasomal cleavage sites of proteins for cytotoxic T cells may soon be fully predictable.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- There are methods available for predicting where the proteasome will cut epitopes that get presented to cytotoxic T cells, but they are still not completely accurate. According to recent research...

Array analysis of autoimmune disease leads to vaccine development.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Researchers have developed protein arrays that could be used to diagnose autoimmune diseases, such as multiple sclerosis, earlier than is currently possible. The approach, described in the...

Targeted DNA vaccine may reverse disease.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Stanford University Medical Center researchers have developed a way to tailor therapies to combat the specific inappropriate responses of autoimmune diseases in mice. The researchers also have shown...

Current developments in cancer vaccines and cellular immunotherapy reviewed.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Investigators have published a review on the current developments in cancer vaccines and cellular immunotherapy. "This article reviews the immunologic basis of clinical trials that test means of...

IL-6 fused to antibody increases immune response against ovarian cancer.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer "Anti-idiotypic (Id) monoclonal antibodies can...

MUC1-derived glycopeptides are strong antigens for breast cancer vaccines.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue According to recent...

Peptide vaccine with adjuvant and CTLA-4 blockade elicits antitumor response.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A protective antitumor immune response was elicited by cytotoxic T lymphocyte epitope peptide vaccination combined with CpG-oligodeoxynucleotide adjuvant and a CTLA-4 blockade. "Although peptide...

Genetically engineered plants produce vaccine components.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Researchers from Germany have genetically engineered plants to produce particles of human papillomavirus (HPV) that could be used in the creation of vaccines or as edible vaccines themselves. They...

ACPM recommends research priorities for child and adolescent immunizations.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- The American College of Preventive Medicine (ACPM) has recommended research priorities that aim to encourage the development of new vaccines and increase immunization rates. Developing new...

Host cell binding prevented for cytomegalovirus coated with AD-2 antibody.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Virus receptor binding was prevented when cytomegalovirus was coated with antibodies specific for antigenic domains 2. According to a study from Germany and Sweden, "Attachment of, and cell-cell...

Venture capital group invests in chloroplast DNA company.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Harris & Harris Group, Inc., announced it has invested $525,900 as part of a convertible preferred financing of privately held Chlorogen, Inc. Investors in this financing include Burrill & Co.,...

BlockAide trial to begin in fourth quarter; scientific advisory board formed.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Adventrx Pharmaceuticals, Inc., (AVRX) announced the formation of its new scientific advisory board, consisting of three well-known academic experts in the areas of anticancer and antiviral development....

Tat-expressing Sendai viral vector-booster does not increase protection.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- No significant enhancement of protection by Tat-expressing Sendai viral vector-booster occurred in a macaque AIDS model. According to a study from Japan, "We previously developed a...

IVIG is immunomodulatory, anti-inflammatory, and provides passive immunization.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Intravenous immunoglobulin acts as an immunomodulatory, anti-inflammatory, and passive immunization providing therapeutic agent. "Intravenous immunoglobulin (IVIG) preparations are fractionated...

Exoerythrocytic stages of Plasmodium inui shortti shown in new world monkeys.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Exoerythrocytic stages of Plasmodium inui shortti have been established in new world monkeys. According to recent research published in the Journal of Parasitology, "Attempts are being made to...

Nasal vaccine may increase protection.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A vaccine administered through the nasal passages may increase protection against pneumococcal disease compared to the current vaccine, say researchers from Albany Medical College in New York and the...

Vaccine provides lifelong immunity.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- More than 90% of people vaccinated for smallpox might retain lifetime immunity to vaccinia, the virus used to vaccinate against the disease, Mark Slifka and colleagues report. The researchers...

Voluntary shots may not protect.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Leaving smallpox vaccinations up to individual Americans could result in many more deaths in the event of terrorist attack, according to a study. The result could be an increase of between 22% and...

Encephalitis is complication of smallpox vaccination.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Encephalitis is a complication of smallpox vaccination that can be prevented by gamma globulin injection. "A smallpox vaccination program has been initiated. The vaccine is a live virus that was...

Recent progress in development of vaccines against tuberculosis reviewed.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A scientist in the United States has published a review of recent progress in the development and testing of vaccines against human tuberculosis. According to recent research published in the...

Mixture of CpG oligodeoxynucleotides may be needed for effective vaccine.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A mixture of immunostimulatory CpG oligodeoxynucleotides (ODNs) may be needed to elicit a reliable immune response in most humans. "Synthetic oligodeoxynucleotides (ODNs) containing unmethylated...

Bacillus spores show promise for vaccine delivery.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Bacillus spores show promise for vaccine delivery. "Spores of the genus Bacillus have been used for a long time as probiotics for oral bacteriotherapy both in humans and in animals. Spores are also...

Effort to develop vaccines against helminth diseases reviewed.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- The development of vaccines against helminth diseases has been reviewed in a recent issue of the International Journal for Parasitology. "The control of helminth diseases of people and livestock...

HIV-1-infected children have impaired immunological memory.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- HIV-infected children who were immunized with "Haemophilus influenzae vaccine exhibited impaired immunological memory. According to a study from Greece, "Haemophilus influenzae type b (Hib)...

Implications of genetic traits on vaccine efficacy outlined.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- The implications of genetic traits on vaccine efficacy have been outlined in a recent issue of Statistics in Medicine. "Literature on genetic screening in the community suggests that people having...

Review of effectiveness of vaccine potency control testing published.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A review of the effectiveness of vaccine potency control testing has been published in a recent issue of the International Journal for Parasitology. "The use of potency control testing is a valuable...

Canarypox virus is a safe vector for use in human p53 cancer vaccine.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- Canarypox virus is a safe vector for use in human p53 cancer vaccine. "Overexpression of p53 occurs in more than 50% of colorectal cancers. Therefore, p53 represents an attractive target antigen for...

Vaccine said to be effective in mice.
September 3, 2003... 2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A mild virus related to dangerous West Nile protected mice from the deadly disease when used as a vaccine, a team of Australian researchers reports. West Nile virus has been spreading rapidly since...

Epitope of SARS-coronavirus nucleocapsid protein identified.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- An epitope of the SARS-coronavirus nucleocapsid protein has been identified. "The nucleocapsid (N) protein of severe acute respiratory syndrome-coronavirus (SARS-CoV) is a major virion structural...

Promising vaccine protects monkeys.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Scientists at the U.S. National Institute of Allergy and Infectious Diseases (NIAID) have created a promising vaccine against West Nile virus by replacing parts of a distantly related virus with...

Peptide-loaded DCs prime T cells better than loaded cross-presenting DCs.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting dendritic cells. According to a study from Denmark,...

Infection of macaques with SIV induces species-specific antibody response.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Infection of macaques with simian immunodeficiency virus induces a species-specific antibody response to major histocompatibility complex class I and class II molecules. According to a study from...

Helicobacter pylori vaccines ready for testing in humans.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Helicobacter pylori vaccines that have shown promise in animal models need to be rigorously tested in humans. "Several lines of evidence from experimental animal models of infection have clearly...

High-throughput antibody screening processes reviewed.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Researchers have published a recent review of high-throughput antibody screening processes. According to recent research published in the journal Trends in Biotechnology, "There are many ways in...

Ethics of Botswana AIDS vaccine trials not assured, group says.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- A Botswana human rights organization has criticized the government for not passing legislation protecting people participating in HIV/AIDS vaccine trials. Alice Mogwe, director of the Botswana...

Indian company says it is developing new vaccine.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- An Indian company says it is conducting trials for an anthrax vaccine that will be safer and cheaper than the vaccine currently used around the world and that it hopes to begin selling by March 2004....

Pilot manufacturing facility for bacterial vaccines planned in Massachusetts.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Avant Immunotherapeutics, Inc., (AVAN) announced that it has reached agreement with MassDevelopment for Avant to occupy and build out a process development and pilot-manufacturing facility in...

Company focusing on proteomics to develop anti-cancer vaccines.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- With capacity to examine 20,000 genes per day, The Windber Research Institute is working on the discovery and administration of vaccines in a trial aimed at stopping the spread of breast and other...

SBIR grant will help fund preclinical development of HER-2/neu peptide vaccine.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corp. (GNBT) announced receipt of a small business innovative research (SBIR) award from the National Cancer Institute to develop a T-helper cell breast cancer vaccine. This...

Vaccine for tumors secreting parathyroid hormone-related protein developed.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- A vaccine that shows promise against tumors, such as prostate cancer tumors, that secrete parathyroid hormone-related protein has been developed. "Parathyroid hormone-related protein (PTH-rP), a...

Vaccination coverage among school-age children approaching goals.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- In the United States, immunization coverage of children entering school remains high and is approaching or exceeding 2010 objectives of greater than 95% in most states. Immunization programs in...

Vaccine maker selects WebForce Express to enhance sales force.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Dendrite International, Inc., (DRTE) announced that Nabi Biopharmaceuticals (NABI), has selected Dendrite's WebForce Express field sales channel management suite to enhance its sales force activities...

Advexin maker reports better-than-expected second quarter results.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Introgen Therapeutics, Inc., (INGN) announced that its results for the quarter ended June 30, 2003, were better than expected, due to a previously outlined cost reduction program that yielded a lower...

Company puts focus on acquiring new technologies, initiating R&D.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- CytRx Corp. (CYTR), a biopharmaceutical company, announced financial results for the 3-month and 6-month periods ended June 30, 2003. For the second quarter of 2003, the company reported a net loss...

Field evaluation of mobility assay for subtyping of HIV-1 described.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Field evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 described in the Ivory Coast. According...

gp120 Thai E and SF2 vaccines elicits immune response in healthy Thai adults.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- A combination of the gp120 Thai E and SF2 vaccines elicited a strong immune response in healthy Thai adults and should be considered for phase 3 clinical testing. According to recent research from...

Delayed hepatitis A booster still effective in people older than 2 years.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Delayed hepatitis A booster is still effective in people older than two years. "Current immunization schedules for hepatitis A vaccine specify administration of a booster within 6-12 or 6-18 months...

Two-dose hepatitis B vaccination schedule immunogenic in adults.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- A two-dose schedule of hepatitis B immunization was immunogenic in adults. According to a study from Pakistan and Cuba, "Healthy subjects (15-50 years old) were randomized to receive,...

Human serum-reactive epitopes in virus-like particles of HPV mapped.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11 have been mapped. According to a study from Sweden and the United States, "Most human antibodies...

Mutational differences occur in the IgG V-H gene in B cells due to ageing.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Mutational differences occur in the IgG V-H gene in B cells due to ageing. According to recent research published in the journal Clinical and Experimental Immunology, "To investigate age related...

Immunity to Listeria occurs without myeloid differentiation factor 88.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Protective cell-mediated immunity to Listeria monocytogenes occurs in the absence of myeloid differentiation factor 88. According to recent research from the United States, "In addition to their...

Company increases influenza vaccine availability to 19 million doses.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Henry Schein, Inc., (HSIC) announced that it has begun to ship what it anticipates to be more than 19 million doses of influenza vaccine for the 2003-2004 influenza season. This shipment...

Serological criteria proposed for licensing pneumococcal vaccine in infants.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Serological criteria have been recommended for the evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. According to a study from an international team of...

Bangladesh polio-free for 3 years, health minister says.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Bangladesh has completed its third year as a polio-free country, but must continue with its massive vaccination program to prevent the crippling disease from entering from neighboring India, a top...

Combined systemic and mucosal OprF-I vaccination enhances immunogenicity.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Combined systemic and mucosal vaccination with the recombinant outer membrane fusion protein of Pseudomonas aeruginosa (OprF-I) enhanced immunogenicity in humans. "We compared the immunogenicity...

West Nile Virus is found in horses from Coahuila State in Northern Mexico.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- West Nile virus is advancing south to Mexico; 62.5% of horses tested were positive in Coahuila in Northern Mexico. "Serum samples were obtained from 24 horses in the State of Coahuila, Mexico, in...

West Nile virus is found in horses from Yucatan State in Mexico.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- West Nile virus is advancing south through Mexico; 1.2% of horses tested were positive in the Yucatan in Mexico. According to a study from the United States, "Serum samples were obtained from 252...

New generation of vaccines to be tested.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Two new investigational smallpox vaccines will be studied as part of a clinical trial starting soon at St. Louis University's Center for Vaccine Development. St. Louis University is the only location...

Researchers publish final results of groundbreaking vaccination study.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Final results of a smallpox vaccine study conducted by researchers at Oregon Health & Science University (OHSU) show America's preparedness for a smallpox outbreak may be greater than initially...

Collaboration targets development of RC-529 adjuvant.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Corixa Corp. (CRXA) and Apovia AG announced a research, development, and commercialization agreement for Corixa's synthetic adjuvant, RC-529. The multiyear agreement grants Apovia commercial rights...

Genome-based screening approach to vaccine development designed.
September 10, 2003... 2003 SEP 10 - (NewsRx.com & NewsRx.net) -- Researchers have designed a genome-based functional screening approach to vaccine development that combines in vitro assays and DNA immunization. "A two-step screening strategy was developed to...

Accelerated Ebola vaccination schedule effective in non-human primates.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- An accelerated Ebola vaccination schedule was effective in protecting non-human primates against Ebola virus hemorrhagic fever. "Containment of highly lethal Ebola virus outbreaks poses a serious...

Baculovirus confers protection from lethal influenza virus infection.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. According to a study from Japan, "A recombinant baculovirus expressing the...

Protein vaccines induce protective and therapeutic antitumor responses.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- HER-2 DNA and protein vaccines containing potent Th cell epitopes induce distinct protective and therapeutic antitumor responses in HER-2 transgenic mice. According to recent research from Denmark,...

Mucosal T cells expressing IL-7 receptor are targets for treatment of colitis.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis. According to recent research published in the Journal of Immunology, "The...

Pneumococcal vaccine modestly effective in HIV patients on HAART.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- The 23-valent pneumococcal polysaccharide vaccine is only modestly effective in HIV-infected patients receiving highly active antiretroviral therapy (HAART). "Whether HAART impacts responses to...

BCG vaccine with recombinant vaccinia virus Ankara boost protects against TB.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Enhanced immunogenicity and protective efficacy was achieved against Mycobacterium tuberculosis using mucosal administration of bacille Calmette-Guerin vaccine and boosting with a recombinant modified...

Pathology and pathogenesis of inhalational anthrax reviewed.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- The pathology and pathogenesis of bioterrorism-related inhalational anthrax has been reviewed in a recent issue of the American Journal of Pathology. "During October and November 2001, public...

Brucella abortus induces TNF and IL-12p40 by MyD88-dependent pathways.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways. "Cattle and humans are susceptible to infection with the Gram-negative intracellular bacterium Brucella...

Early research findings link virus and breast cancer in Australia.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Some cases of breast cancer may be caused by a virus, according to new research by scientists at the University of New South Wales and Prince of Wales Hospital. "More than 40% of Australian breast...

Synergy between vaccine agents yields therapeutic responses in murine tumors.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Synergy between vaccine agents yields therapeutic responses in murine tumors. "This study tested the hypothesis that combination of antiangiogenic therapy and tumor immunotherapy of cancer is...

Tumor cells expressing membrane-bound TNF activate macrophages.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Tumor cells expressing membrane-bound tumor necrosis factor activate macrophages and have a compromised growth in immunosuppressed and immunodeficient mice. According to recent research from...

Vaccine controls tumor-induced immunosuppression in cervical cancer.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- A therapeutic vaccine controlled stromal tumor-induced immunosuppression in human uterine cervix cancer. "Cancer cells may escape immune surveillance by secreting in their microenvironment soluble...

Phase II results of cancer vaccine considered "encouraging".
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Antigenics, Inc., (AGEN) reported that more than half of patients in a phase II clinical trial of the company's personalized cancer vaccine Oncophage (HSPPC-96) had significant immunological response....

Cross-reactivity found between dengue and Japanese encephalitis viruses.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Antibody responses of Japanese dengue fever patients demonstrated cross-reactivity between dengue and Japanese encephalitis viruses. According to published research from Japan, "Titers of...

Emory scientists track down immune sentinel cells with gene gun.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Dendritic cells monitor foreign substances in the body and communicate whether they present a danger to the rest of the immune system. Emory immunologists have developed a sensitive method to detect...

Superior results reported with CAP vaccines.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BISP) announced results of several studies demonstrating the superiority of its innovative calcium phosphate nanoparticulate (CAP) vaccine adjuvant and delivery system,...

Progress made against deadly bug.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Scientists from the Institute for Animal Health announced progress toward controlling the deadly E. coli bacterium that causes food poisoning and kidney failure at the recent Society for General...

Alferon N maker reports second quarter losses; total assets increase.
September 17, 2003... 2003 SEP 17 - (NewsRx.com & NewsRx.net) -- Hemispherx Biopharma, Inc., (HEB) announced losses for the 3 months ended June 30, 2003, of $3,689,000 or $0.11 per share compared to losses of $2,634,000 or $0.08 per share for the same period in...